Logo image of R3NK.DE

RENK GROUP AG (R3NK.DE) Stock Fundamental Analysis

FRA:R3NK - Deutsche Boerse Ag - DE000RENK730 - Common Stock - Currency: EUR

55.41  +2.53 (+4.78%)

Fundamental Rating

4

Taking everything into account, R3NK scores 4 out of 10 in our fundamental rating. R3NK was compared to 106 industry peers in the Machinery industry. Both the profitability and the financial health of R3NK get a neutral evaluation. Nothing too spectacular is happening here. R3NK is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year R3NK was profitable.
R3NK had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: R3NK reported negative net income in multiple years.
In the past 5 years R3NK always reported a positive cash flow from operatings.
R3NK.DE Yearly Net Income VS EBIT VS OCF VS FCFR3NK.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 50M 100M 150M

1.2 Ratios

R3NK has a Return On Assets of 3.36%. This is comparable to the rest of the industry: R3NK outperforms 55.66% of its industry peers.
R3NK's Return On Equity of 12.09% is fine compared to the rest of the industry. R3NK outperforms 70.75% of its industry peers.
R3NK has a Return On Invested Capital (6.64%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for R3NK is below the industry average of 8.60%.
The last Return On Invested Capital (6.64%) for R3NK is above the 3 year average (5.23%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.36%
ROE 12.09%
ROIC 6.64%
ROA(3y)2.22%
ROA(5y)0.83%
ROE(3y)8.35%
ROE(5y)2.21%
ROIC(3y)5.23%
ROIC(5y)3.81%
R3NK.DE Yearly ROA, ROE, ROICR3NK.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

With a decent Profit Margin value of 4.68%, R3NK is doing good in the industry, outperforming 60.38% of the companies in the same industry.
R3NK has a Operating Margin of 10.17%. This is in the better half of the industry: R3NK outperforms 75.47% of its industry peers.
In the last couple of years the Operating Margin of R3NK has grown nicely.
R3NK has a worse Gross Margin (24.53%) than 70.75% of its industry peers.
R3NK's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.17%
PM (TTM) 4.68%
GM 24.53%
OM growth 3Y23.67%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.17%
GM growth 5YN/A
R3NK.DE Yearly Profit, Operating, Gross MarginsR3NK.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 -10 20

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), R3NK is destroying value.
R3NK has about the same amout of shares outstanding than it did 1 year ago.
R3NK has a better debt/assets ratio than last year.
R3NK.DE Yearly Shares OutstandingR3NK.DE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M
R3NK.DE Yearly Total Debt VS Total AssetsR3NK.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

R3NK has an Altman-Z score of 4.13. This indicates that R3NK is financially healthy and has little risk of bankruptcy at the moment.
R3NK has a Altman-Z score of 4.13. This is amongst the best in the industry. R3NK outperforms 90.57% of its industry peers.
R3NK has a debt to FCF ratio of 3.77. This is a good value and a sign of high solvency as R3NK would need 3.77 years to pay back of all of its debts.
R3NK has a Debt to FCF ratio of 3.77. This is in the better half of the industry: R3NK outperforms 64.15% of its industry peers.
A Debt/Equity ratio of 1.20 is on the high side and indicates that R3NK has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.20, R3NK is doing worse than 78.30% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.2
Debt/FCF 3.77
Altman-Z 4.13
ROIC/WACC0.91
WACC7.27%
R3NK.DE Yearly LT Debt VS Equity VS FCFR3NK.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

R3NK has a Current Ratio of 1.82. This is a normal value and indicates that R3NK is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.82, R3NK is doing good in the industry, outperforming 65.09% of the companies in the same industry.
A Quick Ratio of 1.00 indicates that R3NK should not have too much problems paying its short term obligations.
R3NK has a Quick ratio of 1.00. This is comparable to the rest of the industry: R3NK outperforms 50.94% of its industry peers.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1
R3NK.DE Yearly Current Assets VS Current LiabilitesR3NK.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 200M 400M 600M 800M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 64.87% over the past year.
Looking at the last year, R3NK shows a very strong growth in Revenue. The Revenue has grown by 23.23%.
The Revenue has been growing by 17.80% on average over the past years. This is quite good.
EPS 1Y (TTM)64.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%243.74%
Revenue 1Y (TTM)23.23%
Revenue growth 3Y17.8%
Revenue growth 5YN/A
Sales Q2Q%32.75%

3.2 Future

The Earnings Per Share is expected to grow by 29.40% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 16.11% on average over the next years. This is quite good.
EPS Next Y54.17%
EPS Next 2Y37.13%
EPS Next 3Y34.84%
EPS Next 5Y29.4%
Revenue Next Year17.2%
Revenue Next 2Y16.79%
Revenue Next 3Y16.86%
Revenue Next 5Y16.11%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
R3NK.DE Yearly Revenue VS EstimatesR3NK.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
R3NK.DE Yearly EPS VS EstimatesR3NK.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 104.55, R3NK can be considered very expensive at the moment.
Based on the Price/Earnings ratio, R3NK is valued a bit more expensive than the industry average as 68.87% of the companies are valued more cheaply.
R3NK is valuated expensively when we compare the Price/Earnings ratio to 28.22, which is the current average of the S&P500 Index.
R3NK is valuated quite expensively with a Price/Forward Earnings ratio of 40.53.
71.70% of the companies in the same industry are cheaper than R3NK, based on the Price/Forward Earnings ratio.
R3NK is valuated expensively when we compare the Price/Forward Earnings ratio to 20.86, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 104.55
Fwd PE 40.53
R3NK.DE Price Earnings VS Forward Price EarningsR3NK.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

78.30% of the companies in the same industry are cheaper than R3NK, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, R3NK is valued a bit more expensive than the industry average as 65.09% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 39.11
EV/EBITDA 29.25
R3NK.DE Per share dataR3NK.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as R3NK's earnings are expected to grow with 34.84% in the coming years.
PEG (NY)1.93
PEG (5Y)N/A
EPS Next 2Y37.13%
EPS Next 3Y34.84%

2

5. Dividend

5.1 Amount

R3NK has a yearly dividend return of 0.86%, which is pretty low.
Compared to an average industry Dividend Yield of 3.07, R3NK has a dividend in line with its industry peers.
With a Dividend Yield of 0.86, R3NK pays less dividend than the S&P500 average, which is at 2.44.
Industry RankSector Rank
Dividend Yield 0.86%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
R3NK.DE Yearly Dividends per shareR3NK.DE Yearly Dividends per shareYearly Dividends per share 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

R3NK pays out 56.30% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP56.3%
EPS Next 2Y37.13%
EPS Next 3Y34.84%
R3NK.DE Yearly Income VS Free CF VS DividendR3NK.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 50M 100M
R3NK.DE Dividend Payout.R3NK.DE Dividend Payout, showing the Payout Ratio.R3NK.DE Dividend Payout.PayoutRetained Earnings

RENK GROUP AG

FRA:R3NK (5/2/2025, 7:00:00 PM)

55.41

+2.53 (+4.78%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)03-26 2025-03-26
Earnings (Next)05-14 2025-05-14
Inst Owners19.25%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.54B
Analysts83.81
Price Target48.16 (-13.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.86%
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DP56.3%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.77%
Min Revenue beat(2)-1.55%
Max Revenue beat(2)7.09%
Revenue beat(4)3
Avg Revenue beat(4)2.55%
Min Revenue beat(4)-1.55%
Max Revenue beat(4)7.09%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)40.06%
PT rev (3m)54.45%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)6.44%
EPS NY rev (3m)2.05%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)2.51%
Revenue NY rev (3m)4.17%
Valuation
Industry RankSector Rank
PE 104.55
Fwd PE 40.53
P/S 4.86
P/FCF 39.11
P/OCF 32.11
P/B 12.57
P/tB 68.93
EV/EBITDA 29.25
EPS(TTM)0.53
EY0.96%
EPS(NY)1.37
Fwd EY2.47%
FCF(TTM)1.42
FCFY2.56%
OCF(TTM)1.73
OCFY3.11%
SpS11.41
BVpS4.41
TBVpS0.8
PEG (NY)1.93
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.36%
ROE 12.09%
ROCE 10.45%
ROIC 6.64%
ROICexc 7.84%
ROICexgc 12.72%
OM 10.17%
PM (TTM) 4.68%
GM 24.53%
FCFM 12.42%
ROA(3y)2.22%
ROA(5y)0.83%
ROE(3y)8.35%
ROE(5y)2.21%
ROIC(3y)5.23%
ROIC(5y)3.81%
ROICexc(3y)6.06%
ROICexc(5y)4.44%
ROICexgc(3y)10.07%
ROICexgc(5y)7.47%
ROCE(3y)8.22%
ROCE(5y)5.99%
ROICexcg growth 3Y40.48%
ROICexcg growth 5YN/A
ROICexc growth 3Y46.46%
ROICexc growth 5YN/A
OM growth 3Y23.67%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.17%
GM growth 5YN/A
F-Score8
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 1.2
Debt/FCF 3.77
Debt/EBITDA 2.73
Cap/Depr 40.09%
Cap/Sales 2.71%
Interest Coverage 2.23
Cash Conversion 89.39%
Profit Quality 265.67%
Current Ratio 1.82
Quick Ratio 1
Altman-Z 4.13
F-Score8
WACC7.27%
ROIC/WACC0.91
Cap/Depr(3y)34.27%
Cap/Depr(5y)51.64%
Cap/Sales(3y)2.93%
Cap/Sales(5y)4.71%
Profit Quality(3y)329.11%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%243.74%
EPS Next Y54.17%
EPS Next 2Y37.13%
EPS Next 3Y34.84%
EPS Next 5Y29.4%
Revenue 1Y (TTM)23.23%
Revenue growth 3Y17.8%
Revenue growth 5YN/A
Sales Q2Q%32.75%
Revenue Next Year17.2%
Revenue Next 2Y16.79%
Revenue Next 3Y16.86%
Revenue Next 5Y16.11%
EBIT growth 1Y27.59%
EBIT growth 3Y45.68%
EBIT growth 5YN/A
EBIT Next Year80.45%
EBIT Next 3Y37.89%
EBIT Next 5Y30.02%
FCF growth 1Y167.18%
FCF growth 3Y29.47%
FCF growth 5YN/A
OCF growth 1Y112.83%
OCF growth 3Y20.72%
OCF growth 5YN/A